NM_015571.4:c.-523C>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_015571.4(SENP6):c.-523C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0953 in 153,900 control chromosomes in the GnomAD database, including 739 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.095 ( 728 hom., cov: 33)
Exomes 𝑓: 0.087 ( 11 hom. )
Consequence
SENP6
NM_015571.4 5_prime_UTR
NM_015571.4 5_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.804
Publications
7 publications found
Genes affected
SENP6 (HGNC:20944): (SUMO specific peptidase 6) Ubiquitin-like molecules (UBLs), such as SUMO1 (UBL1; MIM 601912), are structurally related to ubiquitin (MIM 191339) and can be ligated to target proteins in a similar manner as ubiquitin. However, covalent attachment of UBLs does not result in degradation of the modified proteins. SUMO1 modification is implicated in the targeting of RANGAP1 (MIM 602362) to the nuclear pore complex, as well as in stabilization of I-kappa-B-alpha (NFKBIA; MIM 164008) from degradation by the 26S proteasome. Like ubiquitin, UBLs are synthesized as precursor proteins, with 1 or more amino acids following the C-terminal glycine-glycine residues of the mature UBL protein. Thus, the tail sequences of the UBL precursors need to be removed by UBL-specific proteases, such as SENP6, prior to their conjugation to target proteins (Kim et al., 2000 [PubMed 10799485]). SENPs also display isopeptidase activity for deconjugation of SUMO-conjugated substrates (Lima and Reverter, 2008 [PubMed 18799455]).[supplied by OMIM, Jun 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.104 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SENP6 | NM_015571.4 | c.-523C>T | 5_prime_UTR_variant | Exon 1 of 24 | ENST00000447266.7 | NP_056386.2 | ||
| SENP6 | NM_001100409.3 | c.-523C>T | 5_prime_UTR_variant | Exon 1 of 23 | NP_001093879.1 | |||
| SENP6 | NM_001304792.2 | c.-523C>T | 5_prime_UTR_variant | Exon 1 of 15 | NP_001291721.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0955 AC: 14508AN: 151980Hom.: 727 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
14508
AN:
151980
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0875 AC: 158AN: 1806Hom.: 11 Cov.: 0 AF XY: 0.0968 AC XY: 110AN XY: 1136 show subpopulations
GnomAD4 exome
AF:
AC:
158
AN:
1806
Hom.:
Cov.:
0
AF XY:
AC XY:
110
AN XY:
1136
show subpopulations
African (AFR)
AF:
AC:
0
AN:
30
American (AMR)
AF:
AC:
2
AN:
24
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
28
East Asian (EAS)
AF:
AC:
4
AN:
46
South Asian (SAS)
AF:
AC:
22
AN:
212
European-Finnish (FIN)
AF:
AC:
1
AN:
62
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
122
AN:
1312
Other (OTH)
AF:
AC:
6
AN:
92
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
6
13
19
26
32
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0954 AC: 14516AN: 152094Hom.: 728 Cov.: 33 AF XY: 0.0958 AC XY: 7121AN XY: 74342 show subpopulations
GnomAD4 genome
AF:
AC:
14516
AN:
152094
Hom.:
Cov.:
33
AF XY:
AC XY:
7121
AN XY:
74342
show subpopulations
African (AFR)
AF:
AC:
3272
AN:
41532
American (AMR)
AF:
AC:
1368
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
326
AN:
3470
East Asian (EAS)
AF:
AC:
201
AN:
5156
South Asian (SAS)
AF:
AC:
494
AN:
4822
European-Finnish (FIN)
AF:
AC:
1344
AN:
10554
Middle Eastern (MID)
AF:
AC:
28
AN:
292
European-Non Finnish (NFE)
AF:
AC:
7183
AN:
67944
Other (OTH)
AF:
AC:
211
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
668
1337
2005
2674
3342
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
158
316
474
632
790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
243
AN:
3472
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.